NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名：Promethazine 25mg/ml 1ml SDA - Box/25生产商：X-GENProduct Code: CP-5525-3NDC Code: 39822-5525-3
产品名称：ISOPROTERENOL HYDROCHLORIDE上市时间：04/26/2023NDA/ANDA/BLA:211703持证商：HIKMANDC:说明书：批准信：
产品名称：GEFITINIB上市时间：04/26/2023NDA/ANDA/BLA:208913持证商：ACTAVIS LABS FL INCNDC:说明书：批准信：
产品名称：CLINDAMYCIN PHOSPHATE上市时间：04/26/2023NDA/ANDA/BLA:208767持证商：CADILANDC:68788-7990-6,72578-084-02,72578-084-03,53002-8371-1,70771-1414-2,70771-1414-3说明书：批准信：
产品名称：CLINDAMYCIN PHOSPHATE上市时间：04/26/2023NDA/ANDA/BLA:208767持证商：CADILANDC:68788-7990-6,72578-084-02,72578-084-03,53002-8371-1,70771-1414-2,70771-1414-3说明书：批准信：
产品名称：ZEJUL上市时间：04/26/2023NDA/ANDA/BLA:208447持证商：GLAXOSMITHKLINENDC:69656-103-30,69656-103-61说明书：httpS://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208447Orig1s000Ltr.pdf
产品名称：SPIRONOLACTONE上市时间：04/26/2023NDA/ANDA/BLA:205936持证商：ZYDUS PHARMSNDC:68382-660-10,68382-660-30,68382-661-10,68382-662-30,68382-662-06,70518-2384-0,70518-2384-2,70518-2385-0,70518-2386-0,68382-660-01,68382-661-06,68382-662-05,68382-662-16,0904-6927-61,51655-636-26,70771-1027-9,70771-1029-9,70518-...
产品名称：METAXALONE上市时间：04/26/2023NDA/ANDA/BLA:203695持证商：ACTAVIS LABS FL INCNDC:60760-093-60,60760-093-90,68788-7018-1,68788-7018-3,55700-911-90,68788-7018-0,45865-985-30,45865-985-90,50436-0449-1,50436-0449-2,50436-0449-3,80425-0131-2,0591-2341-01,60760-093-20,55700-911-30,80425-0131-3,63629-8014-1,636...
产品名称：VERSACLOZ上市时间：04/26/2023NDA/ANDA/BLA:203479持证商：TASMAN PHARMANDC:52817-601-38说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203479s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203479Orig1s000ltr.pdf
产品名称：CLOZAPINE上市时间：04/26/2023NDA/ANDA/BLA:203039持证商：TEVA PHARMS USANDC:0093-5376-01,0093-5376-84,0093-5377-01,0093-5377-84说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203039Orig1s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203039Orig1s000ltr.pdf
产品名称：DUTASTERIDE上市时间：04/26/2023NDA/ANDA/BLA:202660持证商：AUROBINDO PHARMA LTDNDC:59651-021-30,59651-021-90说明书：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=b32611f3-50ec-45bb-a671-ea10cec7829d&type=pdf批准信：
